Safety Study of Larazotide Acetate to Treat Celiac Disease.
Status:
Completed
Trial end date:
2006-01-26
Target enrollment:
Participant gender:
Summary
To demonstrate the safety, pharmacokinetics and efficacy of larazotide acetate in patients
with controlled celiac disease on a gluten-free diet following a gluten challenge.